Evaluation of Clinical Efficacy of Herbal Compound in the Treatment of NSLBP - Trial NCT06336993
Access comprehensive clinical trial information for NCT06336993 through Pure Global AI's free database. This Phase 4 trial is sponsored by Zhejiang Provincial Tongde Hospital and is currently Completed. The study focuses on Low Back Pain. Target enrollment is 71 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Zhejiang Provincial Tongde Hospital
Timeline & Enrollment
Phase 4
Jan 01, 2022
Dec 15, 2023
Primary Outcome
Visual Analogue Scale,Oswestry disability index,Japanese Orthopaedic Association Scores
Summary
The aim of this randomized controlled trial was to explore the clinical efficacy and safety
 of HXTL in the treatment of NSLBP based on TCM principles and to compare the clinical
 outcomes of different syndromes of NSLBP with celecoxib.In this study, 80 patients with NSLBP
 were recruited and randomly grouped to use TCM compound and celeoxib respectively for
 intervention. The pain status and lumbar function use scale of patients were scored before
 intervention, 1 week, 2 weeks and 3 weeks after intervention, and the adverse reactions of
 patients after medication were recorded, and the clinical efficacy of the two groups of
 patients was compared finally.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06336993
Non-Device Trial